Literature DB >> 23183785

The association between serum uric acid and renal damage in a community-based population: the Takahata study.

Kazuko Suzuki1, Tsuneo Konta, Kosuke Kudo, Hiroko Sato, Ami Ikeda, Kazunobu Ichikawa, Yoshiyuki Ueno, Takeo Kato, Takamasa Kayama, Isao Kubota.   

Abstract

BACKGROUND: Hyperuricemia is a risk factor for end-stage renal disease. This study examined the association between serum uric acid and renal damage in a community-based population.
METHODS: In this study 3126 subjects without renal insufficiency were recruited at baseline and were followed for one year. The urinary albumin-creatinine ratio (UACR) and β2-microglobulin-creatinine ratio (UBCR) in morning spot urine samples were used as indices of either glomerular (UACR) or tubular (UBCR) damage.
RESULTS: The mean value of serum uric acid (mg/dL) was 5.8 ± 1.3 (SD) in men and 4.5 ± 1.1 in women. In cross-sectional analysis the increased serum uric acid levels were accompanied by higher UACR values in both men and women (P < 0.01). In contrast, UBCR values were reduced when uric acid levels increased in both men and women (P < 0.01). Multivariate analysis revealed that albuminuria (UACR ≥ 30 mg/g) was significantly associated with increased uric acid (≥7 mg/dL for men, ≥6 mg/dL for women). High UBCR (≥300 μg/g) was negatively associated with uric acid in men, but not in women, after adjustment for possible confounders. In longitudinal analysis in 1388 subjects multiple linear regression analysis showed that uric acid at baseline was an independent factor for one-year increase of UACR [coefficient 4.80 (95 % confidence interval 0.40-9.33) (mg/g) per 1 mg/dL increase in uric acid, P = 0.033].
CONCLUSION: This study showed that serum uric acid concentration was positively associated with UACR, suggesting that uric acid may be related to glomerular damage in a community-based population.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23183785     DOI: 10.1007/s10157-012-0743-y

Source DB:  PubMed          Journal:  Clin Exp Nephrol        ISSN: 1342-1751            Impact factor:   2.801


  17 in total

1.  Mild hyperuricemia induces vasoconstriction and maintains glomerular hypertension in normal and remnant kidney rats.

Authors:  Laura G Sánchez-Lozada; Edilia Tapia; José Santamaría; Carmen Avila-Casado; Virgilia Soto; Tomás Nepomuceno; Bernardo Rodríguez-Iturbe; Richard J Johnson; Jaime Herrera-Acosta
Journal:  Kidney Int       Date:  2005-01       Impact factor: 10.612

2.  The association between renal tubular damage and rapid renal deterioration in the Japanese population: the Takahata study.

Authors:  Kosuke Kudo; Tsuneo Konta; Yusuke Mashima; Kazunobu Ichikawa; Satoshi Takasaki; Ami Ikeda; Masato Hoshikawa; Kazuko Suzuki; Yoko Shibata; Tetsu Watanabe; Takeo Kato; Sumio Kawata; Isao Kubota
Journal:  Clin Exp Nephrol       Date:  2011-01-13       Impact factor: 2.801

3.  Prevalence and risk factor analysis of microalbuminuria in Japanese general population: the Takahata study.

Authors:  T Konta; Z Hao; H Abiko; M Ishikawa; T Takahashi; A Ikeda; K Ichikawa; S Takasaki; I Kubota
Journal:  Kidney Int       Date:  2006-08       Impact factor: 10.612

4.  Uric acid-induced C-reactive protein expression: implication on cell proliferation and nitric oxide production of human vascular cells.

Authors:  Duk-Hee Kang; Sung-Kwang Park; In-Kyu Lee; Richard J Johnson
Journal:  J Am Soc Nephrol       Date:  2005-10-26       Impact factor: 10.121

Review 5.  Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease?

Authors:  Richard J Johnson; Duk-Hee Kang; Daniel Feig; Salah Kivlighn; John Kanellis; Susumu Watanabe; Katherine R Tuttle; Bernardo Rodriguez-Iturbe; Jaime Herrera-Acosta; Marilda Mazzali
Journal:  Hypertension       Date:  2003-04-21       Impact factor: 10.190

6.  Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressure-independent mechanism.

Authors:  Marilda Mazzali; John Kanellis; Lin Han; Lili Feng; Yi-Yang Xia; Qiang Chen; Duk-Hee Kang; Katherine L Gordon; Susumu Watanabe; Takahiko Nakagawa; Hui Y Lan; Richard J Johnson
Journal:  Am J Physiol Renal Physiol       Date:  2002-06

7.  Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971-1992. National Health and Nutrition Examination Survey.

Authors:  J Fang; M H Alderman
Journal:  JAMA       Date:  2000-05-10       Impact factor: 56.272

8.  Serum uric acid level as an independent risk factor for all-cause, cardiovascular, and ischemic stroke mortality: a Chinese cohort study.

Authors:  Jiunn-Horng Chen; Shao-Yuan Chuang; Hsin-Jen Chen; Wen-Ting Yeh; Wen-Harn Pan
Journal:  Arthritis Rheum       Date:  2009-02-15

9.  Revised equations for estimated GFR from serum creatinine in Japan.

Authors:  Seiichi Matsuo; Enyu Imai; Masaru Horio; Yoshinari Yasuda; Kimio Tomita; Kosaku Nitta; Kunihiro Yamagata; Yasuhiko Tomino; Hitoshi Yokoyama; Akira Hishida
Journal:  Am J Kidney Dis       Date:  2009-04-01       Impact factor: 8.860

10.  Plasma uric acid and hypertension in a Chinese community: prospective study and metaanalysis.

Authors:  Weili Zhang; Kai Sun; Ying Yang; Hongye Zhang; Frank B Hu; Rutai Hui
Journal:  Clin Chem       Date:  2009-09-03       Impact factor: 8.327

View more
  7 in total

1.  Associations between serum uric acid levels and the incidence of nonfatal stroke: a nationwide community-based cohort study.

Authors:  Keita Kamei; Tsuneo Konta; Atsushi Hirayama; Kazunobu Ichikawa; Isao Kubota; Shouichi Fujimoto; Kunitoshi Iseki; Toshiki Moriyama; Kunihiro Yamagata; Kazuhiko Tsuruya; Ichiei Narita; Masahide Kondo; Yugo Shibagaki; Masato Kasahara; Koichi Asahi; Tsuyoshi Watanabe
Journal:  Clin Exp Nephrol       Date:  2016-07-12       Impact factor: 2.801

2.  Intensive uric acid-lowering therapy in CKD patients: the protocol for a randomized controlled trial.

Authors:  Masato Kasahara; Yoshihiro Kuwabara; Toshiki Moriyama; Kazuaki Tanabe; Noriko Satoh-Asahara; Tomohiro Katsuya; Shinya Hiramitsu; Hidetaka Shimada; Tosiya Sato; Yoshihiko Saito; Takahiko Nakagawa
Journal:  Clin Exp Nephrol       Date:  2019-11-15       Impact factor: 2.801

3.  Serum Uric Acid and Risk of CKD in Type 2 Diabetes.

Authors:  Salvatore De Cosmo; Francesca Viazzi; Antonio Pacilli; Carlo Giorda; Antonio Ceriello; Sandro Gentile; Giuseppina Russo; Maria C Rossi; Antonio Nicolucci; Pietro Guida; Daniel Feig; Richard J Johnson; Roberto Pontremoli
Journal:  Clin J Am Soc Nephrol       Date:  2015-09-04       Impact factor: 8.237

4.  Association of hyperuricemia with conventional cardiovascular risk factors in elderly patients.

Authors:  Teodoro Marotta; Maria Liccardo; Federico Schettini; Francesco Verde; Aldo L Ferrara
Journal:  J Clin Hypertens (Greenwich)       Date:  2014-11-10       Impact factor: 3.738

5.  Correlation between renal function and common risk factors for chronic kidney disease in a healthy middle-aged population: a prospective observational 2-year study.

Authors:  Michiya Ohno; Fumiko Deguchi; Kumiko Izumi; Hirotoshi Ishigaki; Hiroshi Sarui; Akihiko Sasaki; Tomonori Segawa; Takahiko Yamaki; Takao Kojima; Hiroshige Ohashi
Journal:  PLoS One       Date:  2014-11-14       Impact factor: 3.240

6.  The Toxic Effects of Aflatoxin B1 and Aflatoxin M1 on Kidney through Regulating L-Proline and Downstream Apoptosis.

Authors:  Huiying Li; Lei Xing; Muchen Zhang; Jiaqi Wang; Nan Zheng
Journal:  Biomed Res Int       Date:  2018-08-12       Impact factor: 3.411

7.  Effect and Mechanism of ShiZhiFang on Uric Acid Metabolism in Hyperuricemic Rats.

Authors:  Yansheng Wu; Yixing Wang; Jiaoying Ou; Qiang Wan; Liqiang Shi; Yingqiao Li; Fei He; Huiling Wang; Liqun He; Jiandong Gao
Journal:  Evid Based Complement Alternat Med       Date:  2018-06-25       Impact factor: 2.629

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.